BlackRock
AHCO icon

BlackRock’s AdaptHealth AHCO Stock Holding History

BlackRock’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$167M Buy
16,061,990
+122,037
+0.8% +$1.36M ﹤0.01% 1904
2026
Q1 		$190M Buy
15,939,953
+247,939
+2% +$2.54M ﹤0.01% 1705
2025
Q4 		$156M Buy
15,692,014
+441,070
+3% +$4.21M ﹤0.01% 1845
2025
Q3 		$136M Buy
15,250,944
+132,706
+0.9% +$1.23M ﹤0.01% 1908
2025
Q2 		$143M Sell
15,118,238
-801,812
-5% -$7.07M ﹤0.01% 1822
2025
Q1 		$173M Sell
15,920,050
-536,060
-3% -$5.39M ﹤0.01% 1682
2024
Q4 		$157M Buy
16,456,110
+267,323
+2% +$2.71M ﹤0.01% 1803
2024
Q3 		$182M Buy
16,188,787
+2,613,303
+19% +$27.8M ﹤0.01% 1716
2024
Q2 		$136M Sell
13,575,484
-69,170
-0.5% -$703K ﹤0.01% 1851
2024
Q1 		$157M Sell
13,644,654
-421,911
-3% -$3.58M ﹤0.01% 1799
2023
Q4 		$103M Buy
14,066,565
+924,068
+7% +$7.29M ﹤0.01% 2060
2023
Q3 		$120M Buy
13,142,497
+1,542,284
+13% +$18.5M ﹤0.01% 1888
2023
Q2 		$141M Sell
11,600,213
-275,325
-2% -$3.07M ﹤0.01% 1819
2023
Q1 		$148M Buy
11,875,538
+3,388
+0% +$62.3K ﹤0.01% 1775
2022
Q4 		$228M Sell
11,872,150
-49,857
-0.4% -$1.05M 0.01% 1429
2022
Q3 		$224M Buy
11,922,007
+6,568,394
+123% +$135M 0.01% 1387
2022
Q2 		$96.6M Buy
5,353,613
+71,189
+1% +$1.16M ﹤0.01% 2026
2022
Q1 		$84.7M Sell
5,282,424
-13,652
-0.3% -$245K ﹤0.01% 2238
2021
Q4 		$130M Buy
5,296,076
+34,062
+0.6% +$800K ﹤0.01% 2035
2021
Q3 		$123M Sell
5,262,014
-326,033
-6% -$7.88M ﹤0.01% 2087
2021
Q2 		$153M Buy
5,588,047
+566,410
+11% +$16.2M ﹤0.01% 1970
2021
Q1 		$185M Buy
5,021,637
+3,049,727
+155% +$108M 0.01% 1785
2020
Q4 		$74.1M Buy
1,971,910
+511,637
+35% +$15.8M ﹤0.01% 2249
2020
Q3 		$31.8M Buy
1,460,273
+1,090,557
+295% +$22.9M ﹤0.01% 2575
2020
Q2 		$5.95M Buy
369,716
+363,262
+5,628% +$6.07M ﹤0.01% 3454
2020
Q1 		$103K Buy
+6,454
New +$91.2K ﹤0.01% 4346

Other funds holding AHCO

OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

BlackRock's AHCO Position: Q2 2026 in Review

BlackRock increased its AdaptHealth (AHCO) stake by 0.77% in Q2 2026, buying an estimated $1.36M and bringing the position to 16,061,990 shares worth $167M. The position accounts for ﹤0.01% of the portfolio, ranked #1904.

BlackRock first reported a position in AHCO in Q1 2020 and has held it in 26 quarters since. The position peaked at $228M in Q4 2022. 238 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • BlackRock held 16,061,990 shares of AdaptHealth worth $167M as of Q2 2026.
  • BlackRock bought 122,037 AdaptHealth shares in Q2 2026, an estimated $1.36M.
  • AdaptHealth made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #1904 holding.
  • BlackRock first reported a position in AdaptHealth in Q1 2020 and has held it in 26 quarters since.
  • BlackRock's AdaptHealth position peaked at $228M in Q4 2022.
  • 238 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.